SFX-01 shrinks tumors and extends survival in preclinical models of glioma and glioblastoma Jan. 22, 2021
National University of Singapore, Nanyang Technological University patent RNA editing inhibitors Jan. 21, 2021
FDA accepts C4 Therapeutics' IND for phase I/II trial of CFT-7455 in multiple myeloma and NHL Jan. 21, 2021
Lixte and City of Hope enter agreement to study LB-100 in phase Ib study for extensive stage SCLC Jan. 20, 2021
RSS